ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

PRTG Company Profile and Key Details

NASDAQ : PRTG

Portage Biotech Inc.

$8.26

-0.99-10.70%

At Close 4:00 PM

62.89

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

PRTG Stock Price Chart

Stock Price Today

Portage Biotech Inc. (PRTG) stock declined over -10.70%, trading at $8.26 on NASDAQ, down from the previous close of $9.25. The stock opened at $9.31, fluctuating between $7.97 and $9.58 in the recent session.

Stock Snapshot

9.25

Prev. Close

9.31

Open

9.26M

Market Cap

1.12M

Number of Shares

7.965

Day Low

9.5775

Day High

-0.12

P/E Ratio

24.54%

Free Float in %

-68.17

EPS (TTM)

1.53

Book Value

-0.75

Cash Flow per Share

265.52K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 01, 2025	9.31	9.58	7.96	8.26	262.59K
Mar 31, 2025	8.60	9.89	7.90	9.25	635.61K
Mar 28, 2025	11.95	13.20	8.72	9.60	29.77M
Mar 27, 2025	4.40	4.76	4.40	4.71	10.13K
Mar 26, 2025	4.49	4.69	4.31	4.54	21.95K
Mar 25, 2025	4.29	4.46	4.07	4.07	13.44K
Mar 24, 2025	4.32	4.80	4.18	4.20	96.7K
Mar 21, 2025	4.23	4.28	4.15	4.15	2.9K
Mar 20, 2025	4.20	4.35	4.20	4.35	2.07K
Mar 19, 2025	4.16	4.33	4.16	4.20	3.8K
Mar 18, 2025	4.26	4.30	4.20	4.20	9.53K
Mar 17, 2025	4.39	4.39	4.24	4.25	3.92K
Mar 14, 2025	4.30	4.49	4.04	4.21	21.8K
Mar 13, 2025	4.03	4.43	4.03	4.04	25.12K
Mar 12, 2025	4.02	4.24	4.02	4.05	24.13K
Mar 11, 2025	4.01	4.27	3.92	4.17	24.01K
Mar 10, 2025	4.23	4.39	4.00	4.00	7K
Mar 07, 2025	4.25	4.45	4.20	4.45	5.94K
Mar 06, 2025	4.11	4.45	4.11	4.40	4.22K
Mar 05, 2025	4.30	4.48	4.29	4.40	26.8K

Contact Details

Tortola, VG1110

Virgin Islands, British

Website: https://www.portagebiotech.comContact: 203 221 7378

About Company

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

Frequently Asked Questions

What is the current Portage Biotech Inc. (PRTG) stock price?

Portage Biotech Inc. (NASDAQ: PRTG) stock price is $8.26 in the last trading session. During the trading session, PRTG stock reached the peak price of $9.58 while $7.97 was the lowest point it dropped to. The percentage change in PRTG stock occurred in the recent session was -10.7% while the dollar amount for the price change in PRTG stock was -$0.99.

PRTG's industry and sector of operation?

The NASDAQ listed PRTG is part of Biotechnology industry that operates in the broader Healthcare sector. Portage Biotech Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PRTG?

Mr. Justin Fairchild
Vice President of Devel.
Mr. Allan J. Lee Shaw CPA
Chief Financial Officer
Mr. Allan J. Lee Shaw C.P.A.
Chief Financial Officer
Mr. Brian Wiley
Chief Bus. Officer
Mr. Joseph Ciavarella
Chief Accounting Officer
Dr. Ian B. Walters M.B.A., M.D.
Chief Executive Officer & Chairman of Board
Mr. Steven Innaimo
Vice President of Project Management & Operations
Dr. Robert A. Kramer Ph.D.
Chief Scientific Officer

How PRTG did perform over past 52-week?

PRTG's closing price is 293.33% higher than its 52-week low of $2.10 where as its distance from 52-week high of $23.01 is -64.1%.

How many employees does PRTG have?

Number of PRTG employees currently stands at 7.

Link for PRTG official website?

Official Website of PRTG is: https://www.portagebiotech.com

How do I contact PRTG?

PRTG could be contacted at phone 203 221 7378 and can also be accessed through its website. PRTG operates from Craigmuir Chambers, Tortola, VG1110, Virgin Islands, British.

How many shares of PRTG are traded daily?

PRTG stock volume for the day was 265.52K shares. The average number of PRTG shares traded daily for last 3 months was 610.27K.

What is the market cap of PRTG currently?

The market value of PRTG currently stands at $9.26M with its latest stock price at $8.26 and 1.12M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	7
Beta	1.61
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	March
Sector	Healthcare
Industry	Biotechnology